Blog
RSS FeedPosted by Michael Wonder on 06 Aug 2019
Boris pledges a £1.8 billion cash injection for the NHS
5 August 2019 - There’s nothing like the prospect of a general election to free up funding for the NHS, ...
Posted by Michael Wonder on 03 Aug 2019
NICE expands draft recommendation for Lokelma
31 July 2019 - AstraZeneca has announced that the NICE has issued a positive Final Appraisal Document for Lokelma (sodium ...
Posted by Michael Wonder on 01 Aug 2019
NICE backs Bayer’s Xarelto in new stroke and heart attack prevention use
1 August 2019 - Bayer’s Xarelto (rivaroxaban) can be funded by the NHS to prevent strokes and heart attacks in ...
Posted by Michael Wonder on 01 Aug 2019
Scientific development of HTA—a proposal by the Health Technology Assessment International Scientific Development and Capacity Building Committee
29 July 2019 - This paper is a report from the Scientific Development and Capacity Building Committee of Health Technology ...
Posted by Michael Wonder on 31 Jul 2019
Patient preferences studies: how NICE aims to make use of them
2 July 2019 - Dr Jacoline Bouvy, Senior Scientific Adviser, talks about a growing area of interest for the Scientific ...
Posted by Michael Wonder on 29 Jul 2019
Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art
28 July 2019 - Multi-criteria decision analysis concepts, models and tools have been used increasingly in health technology assessment, with several ...
Posted by Michael Wonder on 27 Jul 2019
Stories of patient involvement impact in health technology assessments: a discussion paper
24 July 2019 - As more health technology assessment bodies seek to implement patient involvement, there is a desire to learn ...
Posted by Michael Wonder on 27 Jul 2019
A non-inferiority framework for cost-effectiveness analysis
24 July 2019 - Traditional decision rules have limitations when a new technology is less effective and less costly than a ...
Posted by Michael Wonder on 26 Jul 2019
Innovative treatment for gynaecological cancers approved for Cancer Drugs Fund
26 July 2019 - Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ...
Posted by Michael Wonder on 22 Jul 2019
NICE numbers at 20
19 July 2019 - Leela Barham takes a look at NICE’s stats on technology appraisals to see how the agency ...
Posted by Michael Wonder on 22 Jul 2019
Government to invest £16 million in 'life-saving' medical advances
22 July 2019 - The Government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, ...
Posted by Michael Wonder on 22 Jul 2019
NICE announces details of health technology evaluation methods review
22 July 2019 - Following approval at its recent Board meeting NICE has confirmed the details of its review of the ...
Posted by Michael Wonder on 17 Jul 2019
Majority of patients not asked for consent before being switched to a biosimilar, survey finds
17 July 2019 - The preliminary survey results showed that 52% of patients received a letter from hospital about switching to ...
Posted by Michael Wonder on 15 Jul 2019
NICE recommends Skyrizi, Forxiga
15 July 2019 - NICE has recommended two new drugs on the NHS, AbbVie’s Skyrizi (risankizumab) and AstraZeneca’s Forxiga (dapagliflozin) ...
Posted by Michael Wonder on 12 Jul 2019
NICE recommends innovative treatment for type 1 diabetes
12 July 2019 - It’s estimated that around 90,000 people could be eligible for treatment with dapagliflozin. ...